UnitedHealth Group Inc. buy Royal Bank of Canada
Start price
29.02.24
/
50%
€456.50
Target price
28.02.25
€551.42
Performance (%)
19.21%
Price
02.08.24
€540.50
Summary
This prediction is currently active. The prediction currently has a performance of 19.21%. Dividends of €3.67 are taken into consideration when calculating the performance. This prediction currently runs until 28.02.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
UnitedHealth Group Inc. | 2.992% | 2.992% |
iShares Core DAX® | -3.935% | -2.628% |
iShares Nasdaq 100 | -3.608% | -9.283% |
iShares Nikkei 225® | -4.513% | -6.951% |
iShares S&P 500 | -2.607% | -4.402% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread UnitedHealth Group Inc. diskutieren
UnitedHealth Group Incorporated (NYSE: UNH) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $596.00 price target on the stock.
Ratings data for UNH provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for UnitedHealth Group Inc.
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€480.00
16.01.24
16.01.24
€547.55
16.01.25
16.01.25
13.37%
02.08.24
02.08.24
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€501.00
30.11.23
30.11.23
€546.23
30.11.24
30.11.24
8.96%
02.08.24
02.08.24
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€510.00
16.10.23
16.10.23
€564.11
16.10.24
16.10.24
7.04%
02.08.24
02.08.24
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€461.00
17.04.23
17.04.23
€542.27
17.04.24
17.04.24
-2.12%
18.04.24
18.04.24